Florida Biologix Signs cGMP Agreement with National Taiwan University Hopsital

Article

Florida Biologix (Alachua, FL), a biopharmaceutical development and contract manufacturing organization, has entered into a current good manufacturing practices (cGMP) manufacturing agreement with the National Taiwan University Hospital (Taipei, Taiwan).

Florida Biologix (Alachua, FL), a biopharmaceutical development and contract manufacturing organization, has entered into a current good manufacturing practices (cGMP) manufacturing agreement with the National Taiwan University Hospital (Taipei, Taiwan). Under the agreement, Florida Biologix will produce a Phase 1 clinical batch of a novel therapy for the rare genetic disease, aromatic amino acid decarboxylase (AADC) deficiency.

Florida Biologix release (PDF)

Recent Videos
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Daniel Fischer, Tevard
Related Content
© 2025 MJH Life Sciences

All rights reserved.